Thalys Medical Technology Group Corporation (SHA:603716)
China
· Delayed Price · Currency is CNY 21.06
+0.15 (0.72%)
Apr 29, 2026, 3:00 PM CST
SHA:603716 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,477 | 4,238 | 1,350 | 2,126 | 2,115 | 2,800 | Upgrade
|
| Market Cap Growth | 130.85% | 213.84% | -36.50% | 0.51% | -24.45% | -14.23% | Upgrade
|
| Enterprise Value | 4,676 | 4,643 | 2,305 | 3,163 | 3,337 | 3,959 | Upgrade
|
| Last Close Price | 20.91 | 20.55 | 7.22 | 11.09 | 11.04 | 14.39 | Upgrade
|
| Forward PE | - | 35.82 | 35.82 | 35.82 | 35.82 | 35.82 | Upgrade
|
| PS Ratio | 4.61 | 3.94 | 0.75 | 1.06 | 0.92 | 1.08 | Upgrade
|
| PB Ratio | 4.54 | 4.68 | 1.40 | 1.62 | 1.41 | 1.61 | Upgrade
|
| P/TBV Ratio | 4.56 | 4.71 | 1.57 | 2.00 | 1.72 | 2.04 | Upgrade
|
| P/FCF Ratio | - | - | 17.68 | 25.00 | - | - | Upgrade
|
| P/OCF Ratio | - | - | 13.56 | 16.89 | 75.23 | - | Upgrade
|
| EV/Sales Ratio | 4.81 | 4.31 | 1.27 | 1.58 | 1.45 | 1.52 | Upgrade
|
| EV/EBITDA Ratio | - | - | 48.74 | 94.19 | 73.79 | 23.73 | Upgrade
|
| EV/EBIT Ratio | - | - | 179.00 | - | - | 41.75 | Upgrade
|
| EV/FCF Ratio | -702.57 | - | 30.18 | 37.19 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.38 | 0.50 | 0.96 | 0.80 | 0.94 | 0.92 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 14.48 | 18.82 | 20.41 | 8.37 | Upgrade
|
| Debt / FCF Ratio | - | - | 12.11 | 12.34 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.24 | 0.36 | 0.74 | 0.59 | 0.68 | 0.64 | Upgrade
|
| Net Debt / EBITDA Ratio | -7.51 | -11.05 | 15.12 | 22.97 | 22.34 | 6.68 | Upgrade
|
| Net Debt / FCF Ratio | -35.93 | -7.45 | 9.37 | 9.07 | -38.10 | -5.75 | Upgrade
|
| Asset Turnover | 0.48 | 0.47 | 0.59 | 0.55 | 0.56 | 0.63 | Upgrade
|
| Inventory Turnover | 3.20 | 3.05 | 4.44 | 4.24 | 4.21 | 4.75 | Upgrade
|
| Quick Ratio | 1.24 | 1.10 | 1.23 | 1.42 | 1.32 | 1.53 | Upgrade
|
| Current Ratio | 1.61 | 1.42 | 1.52 | 1.72 | 1.61 | 1.87 | Upgrade
|
| Return on Equity (ROE) | -21.47% | -21.58% | -16.99% | -11.15% | -11.74% | -2.17% | Upgrade
|
| Return on Assets (ROA) | -1.84% | -1.57% | 0.26% | -0.32% | -0.24% | 1.44% | Upgrade
|
| Return on Invested Capital (ROIC) | -4.82% | -4.00% | 0.68% | -0.82% | -0.58% | 3.51% | Upgrade
|
| Return on Capital Employed (ROCE) | -5.80% | -6.20% | 0.90% | -1.00% | -0.70% | 3.70% | Upgrade
|
| Earnings Yield | -4.70% | -4.89% | -15.50% | -7.46% | -7.27% | -1.77% | Upgrade
|
| FCF Yield | -0.15% | -1.03% | 5.66% | 4.00% | -1.25% | -6.92% | Upgrade
|
| Buyback Yield / Dilution | 0.57% | -3.61% | 0.73% | 0.62% | 1.73% | 0.23% | Upgrade
|
| Total Shareholder Return | 0.57% | -3.61% | 0.73% | 0.62% | 1.73% | 0.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.